A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019)
Clinical trial NCT01698775 · COMPLETED
Trial details
- NCT number
- NCT01698775
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-02
- Primary completion
- 2016-01-19
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.